Defining a Standard Set of Patient-Centered Outcomes for Men With Localized Prostate Cancer

Abstract

Background: Value-based health care has been proposed as a unifying force to drive improved outcomes and cost containment. Objective: To develop a standard set of multidimensional patient-centered health outcomes for tracking, comparing, and improving localized prostate cancer (PCa) treatment value. Design, setting, and participants: We convened an international working group of patients, registry experts, urologists, and radiation oncologists to review existing data and practices. Outcome measurements and statistical analysis: The group defined a recommended standard set representing who should be tracked, what should be measured and at what time points, and what data are necessary to make meaningful comparisons. Using a

Psychometric validation of a German language version of a PROM for urethral stricture surgery and preliminary testing of supplementary ED and UI constructs

“…On the other hand, patients, insurance companies and political players can make their decisions based on health outcome guided data. Most recently, an international working group of patients, registry representatives, urologists and radiation oncologists set up outcome measures including PROM for patients with localized prostate cancer [26]. These measures included treatment approaches, clinicopathologic baseline characteristics, acute complications for surgery and radiation patients, survival and disease control and patientreported health outcomes.…”

Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach

“…ICHOM is supported by an array of organizations, including patient advocacy groups, specialty societies, hospitals and health systems, governments, and private payers The working group convened via six teleconferences between June and December 2014, and proceeded through a structured process similar to that described for the localized prostate cancer set and elsewhere [7][8][9][10] …”

“…We included the Expanded Prostate Cancer Index Composite (EPIC) to assess these complications among men previously treated with local therapy or hormonal therapy because it is a single instrument that assesses the domains of sexual, urinary, hormonal, and bowel function [17]. In addition, it was recommended in the ICHOM localized prostate cancer standard set, allowing a natural continuation of outcome measurement and instrument familiarity for patients who experience recurrence after localized disease [7]. We recommend use of the 26-item form of the EPIC because of its accumulated psychometric evidence.…”

“…The International Consortium for Health Outcomes Measurement (ICHOM) has developed a recommended set of outcomes to be measured in a standardized way for localized prostate cancer, and this set is currently being monitored by a range of registries and provider organizations worldwide [7]. However, no such recommendation exists for advanced prostate cancer.…”

Centralization and Quality Control of Elective Surgery Improve Outcome: Aren’t We Ethically Obliged to Force the Pace of Creating High-volume Centers?

“…Performance feedback via standardized outcome measurement is critical to achieve quality assurance [4]. Martin et al [5] have published a standard set of patient-centered health outcomes that should be tracked and compared to improve the value (defined as outcomes divided by the cost to achieve those outcomes) of localized prostate cancer care. The International Consortium for Health Outcome Measurements (ICHOM) Localized Prostate Cancer working group was initiated by the Martini Clinic and comprises patients, registry experts, urologists, and radiation oncologists.…”